Chemiesynth Vapi reports FY26 loss of ₹98.93 lakh

Chemiesynth (Vapi) Limited reported a net loss of ₹98.93 lakh for the financial year ended March 31, 2026, widening from a loss of ₹10.62 lakh in the previous year. Revenue from operations increased to ₹2144.87 lakh in FY26 from ₹1889.91 lakh in FY25. The company published its audited financial results for the quarter and year ended March 31, 2026, in Indian Express and Financial Express on May 28, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

For the quarter ended March 31, 2026, the company reported a net profit of ₹60.36 lakh, a turnaround from the net loss of ₹69.71 lakh in the quarter ended December 31, 2025. Revenue for the quarter stood at ₹551.60 lakh, compared to ₹508.66 lakh in the preceding quarter. Total comprehensive income for the year was negative at ₹92.68 lakh, compared to ₹35.99 lakh in FY25.

Operational Metrics

Total expenses for FY26 rose to ₹2249.69 lakh from ₹1890.73 lakh in the previous year. The cost of materials consumed increased significantly to ₹537.17 lakh from ₹283.01 lakh. Finance costs also increased to ₹98.89 lakh from ₹79.79 lakh. Earnings per share (EPS) for the year was ₹3.22 loss per share, compared to a loss of ₹0.35 per share in FY25.

Balance Sheet and Cash Flows

The company's total assets stood at ₹3203.02 lakh as of March 31, 2026, slightly down from ₹3219.34 lakh in the previous year. Total equity decreased to ₹1005.38 lakh from ₹1098.06 lakh. Net cash generated from operating activities was ₹189.37 lakh, while net cash used in investing activities was ₹290.54 lakh. Cash and cash equivalents at the end of the year were ₹1.94 lakh.

Particulars	Year Ended 31/03/2026 (₹ in Lakh)	Year Ended 31/03/2025 (₹ in Lakh)
Revenue From Operations	2144.87	1889.91
Total Expenses	2249.69	1890.73
Profit / (Loss) before tax	-104.82	-0.82
Net Profit / (Loss)	-98.93	-10.62
Earnings Per Share (Basic)	-3.22	-0.35

Board Approval and Disclosures

The Board of Directors approved the audited financial results at its meeting held on May 27, 2026. The results were reviewed and recommended by the audit committee. The company operates in a single business segment, the manufacturing of chemicals, and therefore segment reporting is not applicable.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
0.0%	0.0%	+15.75%	+61.12%	+77.62%	+324.40%

Chemiesynth (Vapi) Limited has announced that its board of directors will meet on Wednesday, May 27, 2026. The meeting is scheduled to take place at the company's registered office at 03:00 PM. The primary agenda includes the discussion and approval of the audited financial results for the quarter and fiscal year ended March 31, 2026.

Agenda for the Board Meeting

The board will deliberate on key financial documents and compliance requirements. The specific items listed for consideration include:

To discuss, consider, approve, and take on record the Audited Financial Results of the Company for the quarter and year ended on March 31, 2026, along with the Auditor's report as per Regulation 33 of SEBI (LODR) Regulations, 2015.
Any other items with the permission of the Chair and Majority of Directors.

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading, the trading window for the company's securities has been closed since Wednesday, April 1, 2026. The window will remain closed and shall reopen 48 hours after the declaration of the financial results.

Publication of Results

Following the board meeting, the audited financial results will be uploaded to the company's official website. An extract of the results will also be published in newspapers to ensure broad dissemination of the information to shareholders and the public.